Home › Salivary Gland Cancer
Salivary Gland Cancer clinical trials recruiting in the U.S.
15 studies for Salivary Gland Cancer are recruiting participants at sites across the United States.
Salivary glands empty saliva into your mouth. Salivary gland cancer is a rare type of head and neck cancer. Learn about the associated symptoms.
Cities with the most studies
- Boston, MA5 studies
- Nashville, TN5 studies
- Houston, TX5 studies
- New York City, NY4 studies
- Philadelphia, PA3 studies
- Dallas, TX3 studies
- Highlands Ranch, CO3 studies
By state
- California4 studies
- Colorado5 studies
- Florida4 studies
- Illinois4 studies
- Kansas3 studies
- Massachusetts6 studies
- Minnesota3 studies
- New Jersey3 studies
- New Mexico3 studies
- New York5 studies
- Ohio4 studies
- Pennsylvania4 studies
- Tennessee5 studies
- Texas6 studies
Recently updated studies
DESTINY-PANTUMOUR04
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05408845Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT05884320A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT06695845Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Oropharynx (OPX) Biomarker Trial
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT06356272Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT04620187Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 6, 2026 · NCT03740256Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jan 26, 2026 · NCT05553782VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Dec 11, 2025 · NCT03556228Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 28, 2025 · NCT00898638A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2025 · NCT05941507Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
RecruitingObservational study
Ages 21 to 90 · All sexes · Updated Sep 22, 2025 · NCT00900419Physiologic MR Imaging of Salivary Gland Tumors
Recruiting
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT04452162A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 29, 2025 · NCT06805617From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.